search
Back to results

Inpatient vs Outpatient Management of Short Cervix

Primary Purpose

Preterm Birth, Pregnancy, High Risk

Status
Unknown status
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Inpatient Management
Outpatient Management
Sponsored by
Sunnybrook Health Sciences Centre
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Preterm Birth focused on measuring Preterm Birth, Pregnancy, High Risk, Short Cervix

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Singleton pregnancy between 23 weeks 0 days - 28 weeks 6 days gestational age
  • SC (≤1.5cm) determined by TVS
  • Vaginal progesterone treatment
  • Cervical dilatation of ≤1cm
  • Located within 45 minute drive from recruitment site (Sunnybrook Health Sciences Centre or North York General Hospital)

Exclusion Criteria:

  • Multiple pregnancy
  • Preterm premature rupture of membranes (PPROM), vaginal bleeding, infection, high blood pressure (defined as 140/90 mm Hg or higher)
  • Regular uterine contractions or active labour
  • Vaginal bleeding
  • Cervical dilatation of >1cm
  • Fetal anomalies

Sites / Locations

  • North York General HospitalRecruiting
  • Sunnybrook Health Sciences CentreRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Inpatient Management

Outpatient Management

Arm Description

Women in this arm will follow the standard of care for admission to high-risk units at Sunnybrook Health Sciences Centre or North York General Hospital.

Women in this arm will be encouraged to follow the standard of care established in the high-risk clinics at Sunnybrook Health Sciences Centre or North York General Hospital.

Outcomes

Primary Outcome Measures

Gestational age at delivery

Secondary Outcome Measures

Betamethasone treatment
Magnesium sulphate treatment
Intrapartum complications
Any of the following: cord prolapse, postpartum hemorrhage, or fetal distress
Mode of delivery
One of: vaginal delivery, caesarean section, operative delivery
Patient Quality of Life
36-Item Short Form Health Survey: 36-item, self-administered survey takes 5 minutes and is designed to measure health on eight multi-item dimensions, including functional status, well-being, and overall evaluation of health.
Neonatal morbidity and mortality: composite measure
A composite of the following: Early-onset sepsis/meningitis (culture proven within first 7 days of life), Significant Intraventricular hemorrhage (IVH) (Grade III/IV, hemorrhagic venous infarct), Periventricular leukomalacia (PVL), Respiratory distress syndrome (RDS) (requiring surfactant and ventilation), Need for high frequency oscillatory ventilation (HFO) on Day 1, Need for inhaled nitric oxide (iNO) on Day 1, Pneumothorax (requiring needle aspiration or chest tube drainage), Chronic lung disease (requiring oxygen at discharge/transfer or at corrected gestational age (CGA) 36 weeks), Death, retinopathy of prematurity(ROP) (>Stage 2), necrotizing enterocolitis (NEC) (finding of pneumatosis, portal vein gas or free peritoneal air on abdominal radiograph), patent ductus arteriosus (PDA) (presence of PDA diagnosed by echocardiography or clinical suspicion treated with medication or surgery)

Full Information

First Posted
June 5, 2019
Last Updated
September 27, 2019
Sponsor
Sunnybrook Health Sciences Centre
Collaborators
North York General Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03979196
Brief Title
Inpatient vs Outpatient Management of Short Cervix
Official Title
Inpatient vs Outpatient Management of Women With Short Cervix: A Randomized Controlled Trial (RCT)
Study Type
Interventional

2. Study Status

Record Verification Date
September 2019
Overall Recruitment Status
Unknown status
Study Start Date
June 6, 2019 (Actual)
Primary Completion Date
March 2021 (Anticipated)
Study Completion Date
March 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Sunnybrook Health Sciences Centre
Collaborators
North York General Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The presence of short cervix during pregnancy is a risk factor for preterm birth though in many cases women will eventually deliver at term or near term. While there are proven treatments such as cerclage and progesterone that can improve pregnancy outcomes, many women are advised to limit their activity, are put on bed rest, or admitted to hospital for inpatient management. Presently, there is no evidence that hospital admission of women with short cervix is beneficial and prolongs the pregnancy. The investigators propose to examine whether inpatient management results in comparable outcomes to outpatient management for women with short cervix.
Detailed Description
Preterm birth, defined as the birth of a baby at less than 37 weeks' gestation, is a significant burden to society that is on the rise. Although many risk factors contribute to preterm birth, a short cervix is a well-established risk factor.The most common management for short cervix in Canada is vaginal progesterone, cervical cerclage, and hospital admission. Evidence suggests that vaginal progesterone and cervical cerclage improve outcomes, but there is very limited research on hospital admission or its efficacy. Due to the increased risk of preterm birth associated with cervical length ≤15 mm, some patients are admitted to hospital for observation even though labour is not imminent. The role of inpatient versus outpatient management is unclear and has not been explored. Hospital admission or modified activity has not been shown to improve pregnancy outcomes however, due to the increased risk of preterm birth, many women with short cervix are admitted for inpatient management. This project's objective is to examine whether inpatient or outpatient care results in similar pregnancy outcomes for women with short cervix. This is a multi-centre, non-inferiority randomized controlled trial in women with a singleton pregnancy and isolated short cervix (SC) (≤1.5cm by transvaginal scan (TVS)) at 23-28 weeks at Sunnybrook Health Sciences Centre (SHSC) and North York General Hospital (NYGH), in Toronto, Ontario, Canada. The intervention involves randomizing women to either inpatient or outpatient management and examining whether gestational age at delivery in women with SC (≤1.5cm by TVS) is comparable between arms. The investigators hypothesize that there will be no difference in the preterm birth rate and gestational age at delivery between the two groups.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Preterm Birth, Pregnancy, High Risk
Keywords
Preterm Birth, Pregnancy, High Risk, Short Cervix

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
134 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Inpatient Management
Arm Type
Active Comparator
Arm Description
Women in this arm will follow the standard of care for admission to high-risk units at Sunnybrook Health Sciences Centre or North York General Hospital.
Arm Title
Outpatient Management
Arm Type
Active Comparator
Arm Description
Women in this arm will be encouraged to follow the standard of care established in the high-risk clinics at Sunnybrook Health Sciences Centre or North York General Hospital.
Intervention Type
Other
Intervention Name(s)
Inpatient Management
Intervention Description
Admission for a minimum of three days, administration of betamethasone, and clinical reassessment by obstetrician after three days. After the initial three day admission, further management will be at the discretion of their obstetrician who will continue their care and decide if further admissions are needed. Weekly cervical length assessment will be performed until 28 weeks and patient readmission will be decided by their Obstetrician. Post-intervention, women in both arms will receive the same standard of care (weekly clinic or inpatient follow-up appointments) and will be followed to delivery. Prior to delivery, participants will complete a patient Quality of Life survey and at delivery, primary and secondary outcomes will be collected.
Intervention Type
Other
Intervention Name(s)
Outpatient Management
Intervention Description
Avoid heavy lifting and core exercise, avoid intercourse, weekly assessment of cervical length by ultrasound and administration of betamethasone. Patients will continue with outpatient management for the remainder of their pregnancy with no admission unless the patient develops contractions, PPROM, bleeding, or the cervix is dilated to ≥1cm. Post-intervention, women in both arms will receive the same standard of care (weekly clinic or inpatient follow-up appointments) and will be followed to delivery. Prior to delivery, participants will complete a patient Quality of Life survey and at delivery, primary and secondary outcomes will be collected.
Primary Outcome Measure Information:
Title
Gestational age at delivery
Time Frame
At delivery
Secondary Outcome Measure Information:
Title
Betamethasone treatment
Time Frame
Before delivery
Title
Magnesium sulphate treatment
Time Frame
Before 32 weeks gestation
Title
Intrapartum complications
Description
Any of the following: cord prolapse, postpartum hemorrhage, or fetal distress
Time Frame
During delivery
Title
Mode of delivery
Description
One of: vaginal delivery, caesarean section, operative delivery
Time Frame
At delivery
Title
Patient Quality of Life
Description
36-Item Short Form Health Survey: 36-item, self-administered survey takes 5 minutes and is designed to measure health on eight multi-item dimensions, including functional status, well-being, and overall evaluation of health.
Time Frame
1 week after randomization
Title
Neonatal morbidity and mortality: composite measure
Description
A composite of the following: Early-onset sepsis/meningitis (culture proven within first 7 days of life), Significant Intraventricular hemorrhage (IVH) (Grade III/IV, hemorrhagic venous infarct), Periventricular leukomalacia (PVL), Respiratory distress syndrome (RDS) (requiring surfactant and ventilation), Need for high frequency oscillatory ventilation (HFO) on Day 1, Need for inhaled nitric oxide (iNO) on Day 1, Pneumothorax (requiring needle aspiration or chest tube drainage), Chronic lung disease (requiring oxygen at discharge/transfer or at corrected gestational age (CGA) 36 weeks), Death, retinopathy of prematurity(ROP) (>Stage 2), necrotizing enterocolitis (NEC) (finding of pneumatosis, portal vein gas or free peritoneal air on abdominal radiograph), patent ductus arteriosus (PDA) (presence of PDA diagnosed by echocardiography or clinical suspicion treated with medication or surgery)
Time Frame
1-28 days post-delivery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Singleton pregnancy between 23 weeks 0 days - 28 weeks 6 days gestational age SC (≤1.5cm) determined by TVS Vaginal progesterone treatment Cervical dilatation of ≤1cm Located within 45 minute drive from recruitment site (Sunnybrook Health Sciences Centre or North York General Hospital) Exclusion Criteria: Multiple pregnancy Preterm premature rupture of membranes (PPROM), vaginal bleeding, infection, high blood pressure (defined as 140/90 mm Hg or higher) Regular uterine contractions or active labour Vaginal bleeding Cervical dilatation of >1cm Fetal anomalies
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Susan O'Rinn, BA
Phone
416-480-6100
Ext
87716
Email
susan.orinn@sunnybrook.ca
First Name & Middle Initial & Last Name or Official Title & Degree
Ori Nevo, MD
Phone
416-480-6100
Ext
87704
Email
ori.nevo@sunnybrook.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ori Nevo, MD
Organizational Affiliation
Sunnybrook Health Sciences Centre
Official's Role
Principal Investigator
Facility Information:
Facility Name
North York General Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M2K 1E1
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Elad Mei-Dan, MD
Phone
(647) 891-2707
Email
Elad.Mei-Dan@nygh.on.ca
First Name & Middle Initial & Last Name & Degree
Elad Mei-Dan, MD
Facility Name
Sunnybrook Health Sciences Centre
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M4N 3M5
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ori Nevo, MD
Phone
(416) 480 6100
Ext
87704
Email
ori.nevo@sunnybrook.ca
First Name & Middle Initial & Last Name & Degree
Susan O'Rinn, BA
Phone
(416) 480 6100
Ext
87716
Email
susan.orinn@sunnybrook.ca
First Name & Middle Initial & Last Name & Degree
Ori Nevo, MD
First Name & Middle Initial & Last Name & Degree
Jon FR Barrett, MD
First Name & Middle Initial & Last Name & Degree
Stefania Ronzoni, MD, PhD
First Name & Middle Initial & Last Name & Degree
Alex Kiss, PhD
First Name & Middle Initial & Last Name & Degree
Aimee Santoro, NP
First Name & Middle Initial & Last Name & Degree
Susan O'Rinn, BA

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
23265368
Citation
Menon R. Preterm birth: a global burden on maternal and child health. Pathog Glob Health. 2012 Jul;106(3):139-40. doi: 10.1179/204777312X13462106637729. No abstract available.
Results Reference
background
PubMed Identifier
24366461
Citation
Blencowe H, Lee AC, Cousens S, Bahalim A, Narwal R, Zhong N, Chou D, Say L, Modi N, Katz J, Vos T, Marlow N, Lawn JE. Preterm birth-associated neurodevelopmental impairment estimates at regional and global levels for 2010. Pediatr Res. 2013 Dec;74 Suppl 1(Suppl 1):17-34. doi: 10.1038/pr.2013.204.
Results Reference
background
PubMed Identifier
22682464
Citation
Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, Adler A, Vera Garcia C, Rohde S, Say L, Lawn JE. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012 Jun 9;379(9832):2162-72. doi: 10.1016/S0140-6736(12)60820-4.
Results Reference
background
PubMed Identifier
12509596
Citation
Alexander GR, Kogan M, Bader D, Carlo W, Allen M, Mor J. US birth weight/gestational age-specific neonatal mortality: 1995-1997 rates for whites, hispanics, and blacks. Pediatrics. 2003 Jan;111(1):e61-6. doi: 10.1542/peds.111.1.e61.
Results Reference
background
PubMed Identifier
20669423
Citation
Institute of Medicine (US) Committee on Understanding Premature Birth and Assuring Healthy Outcomes; Behrman RE, Butler AS, editors. Preterm Birth: Causes, Consequences, and Prevention. Washington (DC): National Academies Press (US); 2007. Available from http://www.ncbi.nlm.nih.gov/books/NBK11362/
Results Reference
background
PubMed Identifier
15752534
Citation
Lawn JE, Cousens S, Zupan J; Lancet Neonatal Survival Steering Team. 4 million neonatal deaths: when? Where? Why? Lancet. 2005 Mar 5-11;365(9462):891-900. doi: 10.1016/S0140-6736(05)71048-5.
Results Reference
background
PubMed Identifier
3880598
Citation
McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med. 1985 Jan 10;312(2):82-90. doi: 10.1056/NEJM198501103120204.
Results Reference
background
PubMed Identifier
8174665
Citation
Berkowitz GS, Papiernik E. Epidemiology of preterm birth. Epidemiol Rev. 1993;15(2):414-43. doi: 10.1093/oxfordjournals.epirev.a036128. No abstract available.
Results Reference
background
PubMed Identifier
8569824
Citation
Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A, Thom E, McNellis D, Copper RL, Johnson F, Roberts JM. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med. 1996 Feb 29;334(9):567-72. doi: 10.1056/NEJM199602293340904.
Results Reference
background
PubMed Identifier
9339522
Citation
Berghella V, Kuhlman K, Weiner S, Texeira L, Wapner RJ. Cervical funneling: sonographic criteria predictive of preterm delivery. Ultrasound Obstet Gynecol. 1997 Sep;10(3):161-6. doi: 10.1046/j.1469-0705.1997.10030161.x.
Results Reference
background
PubMed Identifier
17666605
Citation
Berghella V, Roman A, Daskalakis C, Ness A, Baxter JK. Gestational age at cervical length measurement and incidence of preterm birth. Obstet Gynecol. 2007 Aug;110(2 Pt 1):311-7. doi: 10.1097/01.AOG.0000270112.05025.1d.
Results Reference
background
PubMed Identifier
18412093
Citation
Crane JM, Hutchens D. Transvaginal sonographic measurement of cervical length to predict preterm birth in asymptomatic women at increased risk: a systematic review. Ultrasound Obstet Gynecol. 2008 May;31(5):579-87. doi: 10.1002/uog.5323.
Results Reference
background
PubMed Identifier
10739521
Citation
Goldenberg RL, Iams JD, Das A, Mercer BM, Meis PJ, Moawad AH, Miodovnik M, VanDorsten JP, Caritis SN, Thurnau GR, Dombrowski MP, Roberts JM, McNellis D. The Preterm Prediction Study: sequential cervical length and fetal fibronectin testing for the prediction of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 2000 Mar;182(3):636-43. doi: 10.1067/mob.2000.104212.
Results Reference
background
PubMed Identifier
11555447
Citation
Guzman ER, Walters C, Ananth CV, O'Reilly-Green C, Benito CW, Palermo A, Vintzileos AM. A comparison of sonographic cervical parameters in predicting spontaneous preterm birth in high-risk singleton gestations. Ultrasound Obstet Gynecol. 2001 Sep;18(3):204-10. doi: 10.1046/j.0960-7692.2001.00526.x.
Results Reference
background
PubMed Identifier
9819868
Citation
Heath VC, Southall TR, Souka AP, Elisseou A, Nicolaides KH. Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol. 1998 Nov;12(5):312-7. doi: 10.1046/j.1469-0705.1998.12050312.x.
Results Reference
background
PubMed Identifier
14714921
Citation
Owen J. Evaluation of the cervix by ultrasound for the prediction of preterm birth. Clin Perinatol. 2003 Dec;30(4):735-55. doi: 10.1016/s0095-5108(03)00103-9.
Results Reference
background
PubMed Identifier
16682111
Citation
Ozdemir I, Demirci F, Yucel O, Erkorkmaz U. Ultrasonographic cervical length measurement at 10-14 and 20-24 weeks gestation and the risk of preterm delivery. Eur J Obstet Gynecol Reprod Biol. 2007 Feb;130(2):176-9. doi: 10.1016/j.ejogrb.2006.03.021. Epub 2006 May 8.
Results Reference
background
PubMed Identifier
11339192
Citation
Cicero S, Skentou C, Souka A, To MS, Nicolaides KH. Cervical length at 22-24 weeks of gestation: comparison of transvaginal and transperineal-translabial ultrasonography. Ultrasound Obstet Gynecol. 2001 Apr;17(4):335-40. doi: 10.1046/j.1469-0705.2001.00345.x.
Results Reference
background
PubMed Identifier
15124188
Citation
Yazici G, Yildiz A, Tiras MB, Arslan M, Kanik A, Oz U. Comparison of transperineal and transvaginal sonography in predicting preterm delivery. J Clin Ultrasound. 2004 Jun;32(5):225-30. doi: 10.1002/jcu.20027.
Results Reference
background
PubMed Identifier
2206073
Citation
Andersen HF, Nugent CE, Wanty SD, Hayashi RH. Prediction of risk for preterm delivery by ultrasonographic measurement of cervical length. Am J Obstet Gynecol. 1990 Sep;163(3):859-67. doi: 10.1016/0002-9378(90)91084-p.
Results Reference
background
PubMed Identifier
21472815
Citation
Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, Vijayaraghavan J, Trivedi Y, Soma-Pillay P, Sambarey P, Dayal A, Potapov V, O'Brien J, Astakhov V, Yuzko O, Kinzler W, Dattel B, Sehdev H, Mazheika L, Manchulenko D, Gervasi MT, Sullivan L, Conde-Agudelo A, Phillips JA, Creasy GW; PREGNANT Trial. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011 Jul;38(1):18-31. doi: 10.1002/uog.9017. Epub 2011 Jun 15.
Results Reference
background
PubMed Identifier
28276151
Citation
Jarde A, Lutsiv O, Park CK, Beyene J, Dodd JM, Barrett J, Shah PS, Cook JL, Saito S, Biringer AB, Sabatino L, Giglia L, Han Z, Staub K, Mundle W, Chamberlain J, McDonald SD. Effectiveness of progesterone, cerclage and pessary for preventing preterm birth in singleton pregnancies: a systematic review and network meta-analysis. BJOG. 2017 Jul;124(8):1176-1189. doi: 10.1111/1471-0528.14624. Epub 2017 Apr 17.
Results Reference
background
PubMed Identifier
20014326
Citation
Sotiriadis A, Papatheodorou S, Kavvadias A, Makrydimas G. Transvaginal cervical length measurement for prediction of preterm birth in women with threatened preterm labor: a meta-analysis. Ultrasound Obstet Gynecol. 2010 Jan;35(1):54-64. doi: 10.1002/uog.7457.
Results Reference
background
PubMed Identifier
14974024
Citation
Sosa C, Althabe F, Belizan J, Bergel E. Bed rest in singleton pregnancies for preventing preterm birth. Cochrane Database Syst Rev. 2004;(1):CD003581. doi: 10.1002/14651858.CD003581.pub2.
Results Reference
background
PubMed Identifier
17195150
Citation
Fox NS, Jean-Pierre C, Predanic M, Chasen ST. Does hospitalization prevent preterm delivery in the patient with a short cervix? Am J Perinatol. 2007 Jan;24(1):49-53. doi: 10.1055/s-2006-958164. Epub 2006 Dec 27.
Results Reference
background
PubMed Identifier
23812450
Citation
Grobman WA, Gilbert SA, Iams JD, Spong CY, Saade G, Mercer BM, Tita ATN, Rouse DJ, Sorokin Y, Leveno KJ, Tolosa JE, Thorp JM, Caritis SN, Peter Van Dorsten J; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network*. Activity restriction among women with a short cervix. Obstet Gynecol. 2013 Jun;121(6):1181-1186. doi: 10.1097/AOG.0b013e3182917529.
Results Reference
background
PubMed Identifier
28454755
Citation
Shea AK, Simpson AN, Barrett J, Ladhani N, Nevo O. Pregnancy Outcomes of Women Admitted to a Tertiary Care Centre with Short Cervix. J Obstet Gynaecol Can. 2017 May;39(5):328-334. doi: 10.1016/j.jogc.2017.01.012.
Results Reference
background
PubMed Identifier
1593914
Citation
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.
Results Reference
background
Citation
Provencher et al. Fertility: Overview, 2012 to 2016. Reports on the Demographic Situation in Canada. 2018; Catalogue no. 91-209-X.
Results Reference
background
Citation
Copyright © 2013, SAS Institute Inc., Cary, NC, USA.
Results Reference
background

Learn more about this trial

Inpatient vs Outpatient Management of Short Cervix

We'll reach out to this number within 24 hrs